Journal of Clinical Apheresis 28:145–Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth

First Page		Document Content
Date: 2016-05-24 18:07:21 Transfusion medicine Apheresis LDL apheresis Erythrocytapheresis Hematopoietic stem cell transplantation Plateletpheresis Plasmapheresis Thrombotic thrombocytopenic purpura Levels of evidence Extracorporeal Cholesterol Platelet		Journal of Clinical Apheresis 28:145–Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Add to Reading List Source URL: inbcsaves.org Download Document from Source Website File Size: 4,01 MB Share Document on Facebook

	Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero Cataland, Flora Peyvandi, Paul Coppo, DocID: 1utac - View Document
	IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic DocID: 1pS8s - View Document
	Journal of Clinical Apheresis 28:145–Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth DocID: 1pqG9 - View Document
	Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products Address for correspondence: BCSH Secretary British Society for Haematology DocID: 176UN - View Document
	Journal of the Hong Kong Geriatrics Society • Vol. 10 No.2 JulyAN ELDERLY GENTLEMAN WITH SUSPECTED RECURRENT STROKE AND TICLOPIDINE INDUCED THROMBOTIC THROMBOCYTOPENIC PURPURA YW Shum. MBBS (HK), MRCP (UK), FHKA DocID: 14YuY - View Document